VRTT VRTT

Viatar CTC Solutions (CE) Stock Price

0.001
0.00 (0.0%)
0.001
Volume 0.00
Bid Price 0.001
Ask Price 0.001
News -
Day High

Low
0.001

52 Week Range

High
0.0208

Day Low
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Canna Trader Pro
Monthly Subscription
for only
$59.99
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Viatar CTC Solutions Inc (CE) VRTT OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.001 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.001 0.001
Trades Volume Avg Volume 52 Week Range
0 0.00 - 0.001 - 0.0208
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.001 USD

Period:

Draw Mode:

Viatar CTC Solutions Inc (CE) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 19.72k 19.72M 9.40M $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
3.30k $ - - - -

more financials information »

Viatar CTC Solutions (CE) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical VRTT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.0%
1 Month0.000.000.000.0000.000.0%
3 Months0.000.000.000.0000.000.0%
6 Months0.000.000.000.0000.000.0%
1 Year0.01920.02080.0010.006165619,250-0.0182-94.79%
3 Years0.070.300.0010.030490510,074-0.069-98.57%
5 Years0.2150.600.0010.276780516,081-0.214-99.53%

Viatar CTC Solutions (CE) Description

Viatar CTC Solutions Inc. is a medical technology company focused on the treatment of patients with metastatic cancer. The company's lead product, the Viatar Therapeutic Oncopheresis System, removes circulating tumor cells from whole blood using label-free cross-flow filtration. Pending regulatory approval targeted for 2016, it will be used as a periodic therapy to improve overall survival for a wide range of solid tumor types such as lung, breast, colon, prostate and gastric cancers. This proprietary technology also powers the company's liquid biopsy products, which are collection systems for use by genetic testing companies, researchers and medical oncologists that provide a greater quantity and purity of circulating tumor cells for their molecular analysis and personalized medicine objectives.


Your Recent History
USOTC
VRTT
Viatar CTC..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.